Bosentan may be an effective therapy for patients with chronic thromboembolic pulmonary hypertension

By  

Inpharma, Vol. 1, Iss. 1605, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Inhaled treprostinil is an effective, well-tolerated add-on therapy for patients with pulmonary arterial hypertension (PAH) treated with bosentan

By  

Inpharma, Vol. 1, Iss. 1561, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Sitaxsentan sodium appears to be more cost effective than bosentan in treating patients with pulmonary arterial hypertension (PAH)

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 508, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Bosentan improves exercise capacity in pulmonary hypertension

By  

Inpharma, Vol. 1, Iss. 1309, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Bosentan: In Pediatric Patients with Pulmonary Arterial Hypertension

By Carter Natalie J.   Keating Gillian M.  

Pediatric Drugs, Vol. 12, Iss. 1, 2010-02 ,pp. : 63-73

Adis International

Access to resources Recommend Favorite